Beta Endorphins,Interleukin 1 and Interleukin 38 in Covid Patients Associated With Neuropsychological Manifestations.

NCT05198388 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2022-01-25

No results posted yet for this study

Summary

Measurement of Beta endorphins,interleukin 1 and interleukin 38 in covid patients associated with neuropsychological manifestations.

Conditions

  • Covid Patients

Interventions

DIAGNOSTIC_TEST

βeta endorphins, interleukin 6 and interleukin 38

* \- Collection of peripheral blood samples in gel tube. * \- Creparation of samples in centrifuge to obtain serum. * \- Measurement of interleukin 6 and interleukin 38 and βeta endorphins using ELISA method.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
2 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2024-03-30
Completion
2024-03-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05198388 on ClinicalTrials.gov